BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18248333)

  • 1. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.
    Biasiolo A; Chemello L; Quarta S; Cavalletto L; Bortolotti F; Caberlotto C; Beneduce L; Bernardinello E; Tono N; Fassina G; Gatta A; Pontisso P
    J Viral Hepat; 2008 Apr; 15(4):246-9. PubMed ID: 18248333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
    Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
    Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
    Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
    Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
    Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
    J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease.
    Turato C; Ruvoletto MG; Biasiolo A; Quarta S; Tono N; Bernardinello E; Beneduce L; Fassina G; Cavalletto L; Chemello L; Merkel C; Gatta A; Pontisso P
    Dig Liver Dis; 2009 Mar; 41(3):212-6. PubMed ID: 18657489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
    Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
    Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
    Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
    J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
    Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
    Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis.
    Cagnin M; Biasiolo A; Martini A; Ruvoletto M; Quarta S; Fasolato S; Angeli P; Fassina G; Pontisso P
    Sci Rep; 2019 Dec; 9(1):20126. PubMed ID: 31882893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.
    Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G
    Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
    Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
    PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations.
    Calabrese F; Lunardi F; Giacometti C; Marulli G; Gnoato M; Pontisso P; Saetta M; Valente M; Rea F; Perissinotto E; Agostini C
    Thorax; 2008 Sep; 63(9):795-802. PubMed ID: 18344408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
    Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
    J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
    Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
    Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.
    Chen CH; Tsai TL; Yang YS; Tsai CC
    J Oral Pathol Med; 2007 Feb; 36(2):83-7. PubMed ID: 17238969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.